Juan Antonio Carrasco

Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study

Xavier García del Muro, Antonio López–Pousa, Joan Maurel et al. · Journal of Clinical Oncology · 2011 · 298 citations

Medicine, Oncology, Pharmacotherapy +12

Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study

Javier Martín‐Broto, Antonio López–Pousa, Xavier García del Muro et al. · Journal of Clinical Oncology · 2016 · 74 citations

Medicine, Oncology, Pharmacology +13

Phase II clinical trial evaluating the activity and tolerability of pazopanib in patients (pts) with advanced and/or metastatic liposarcoma (LPS): A joint Spanish Sarcoma Group (GEIS) and German Interdisciplinary Sarcoma Group (GISG) Study—NCT01692496.

Claudia Valverde, Javier Martín‐Broto, José A. López-Martín et al. · Journal of Clinical Oncology · 2016 · 18 citations

Medicine, Oncology, Pharmacology +10

Incorporating the explicit role of psychological factors on mode choice: a hybrid mode choice model by using data from an innovative psychometric survey

Alejandro Tudela, Khandker Nurul Habib, Juan Antonio Carrasco et al. · 2011 · 14 citations

Social Sciences, Behavioral Sciences, Psychology +17

SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022)

César Serrano, Rosa Álvarez, Juan Antonio Carrasco et al. · Clinical & Translational Oncology · 2023 · 14 citations · Full text

Medicine, Oncology, Pharmacotherapy +16